JP2022524753A5 - - Google Patents
Info
- Publication number
- JP2022524753A5 JP2022524753A5 JP2021552690A JP2021552690A JP2022524753A5 JP 2022524753 A5 JP2022524753 A5 JP 2022524753A5 JP 2021552690 A JP2021552690 A JP 2021552690A JP 2021552690 A JP2021552690 A JP 2021552690A JP 2022524753 A5 JP2022524753 A5 JP 2022524753A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- globin
- antitumor
- cancer
- liposome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1902992.5A GB201902992D0 (en) | 2019-03-06 | 2019-03-06 | Product and method |
| GB1902992.5 | 2019-03-06 | ||
| PCT/GB2020/050537 WO2020178598A1 (en) | 2019-03-06 | 2020-03-06 | Antitumor cell comprising a charge modified globin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022524753A JP2022524753A (ja) | 2022-05-10 |
| JP2022524753A5 true JP2022524753A5 (enExample) | 2023-03-09 |
Family
ID=66377289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552690A Pending JP2022524753A (ja) | 2019-03-06 | 2020-03-06 | 電荷修飾グロビンを含む抗腫瘍細胞 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220127317A1 (enExample) |
| EP (1) | EP3934667A1 (enExample) |
| JP (1) | JP2022524753A (enExample) |
| KR (1) | KR20210135567A (enExample) |
| CN (1) | CN113891719A (enExample) |
| AU (1) | AU2020231078A1 (enExample) |
| CA (1) | CA3131161A1 (enExample) |
| GB (1) | GB201902992D0 (enExample) |
| WO (1) | WO2020178598A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20260234195A1 (en) * | 2021-11-05 | 2026-08-13 | University Of Kansas | Active immunization against amyloid and aging-related diseases |
| GB202200962D0 (en) | 2022-01-25 | 2022-03-09 | Cytoseek Ltd | Polymer additives |
| WO2025137409A1 (en) * | 2023-12-21 | 2025-06-26 | University Of Florida Research Foundation, Incorporated | Supercharged lipid nanodiscs and methods of use |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2297182A4 (en) | 2008-04-28 | 2012-08-15 | Harvard College | HIGHLY CHARGED PROTEINS USED FOR CELL PENETRATION |
| JP2010215517A (ja) * | 2009-03-13 | 2010-09-30 | Terumo Corp | 酸素親和性を中酸素親和性に制御したヘモグロビン含有リポソーム懸濁液 |
| WO2010129023A2 (en) | 2009-04-28 | 2010-11-11 | President And Fellows Of Harvard College | Supercharged proteins for cell penetration |
| CA2849448C (en) * | 2011-09-06 | 2020-03-24 | Billion King International Limited | Oral delivery for hemoglobin based oxygen carriers |
| FR3002146B1 (fr) | 2013-02-15 | 2016-03-04 | Hemarina | Utilisation d'hemoglobine d'annelides pour traiter les cancers |
| JP6618892B2 (ja) | 2013-04-23 | 2019-12-11 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 細菌バイオフィルムの遺伝的リプログラミング |
| EP3043819A4 (en) * | 2013-09-11 | 2017-04-05 | Compugen Ltd. | Anti-vstm5 antibodies and the use thereof in therapy and diagnosis |
| EP3212221B1 (en) | 2014-10-29 | 2023-12-06 | Massachusetts Eye & Ear Infirmary | Efficient delivery of therapeutic molecules in vitro and in vivo |
| CN106137967B (zh) * | 2015-04-24 | 2019-05-14 | 北京大学 | 靶向脑胶质瘤的双重修饰脂质体给药系统的制备和应用 |
| CN109790519A (zh) * | 2016-06-22 | 2019-05-21 | 塞尔丽思股份公司 | 细胞靶向的药物活性物质或标记物递送体系 |
-
2019
- 2019-03-06 GB GBGB1902992.5A patent/GB201902992D0/en not_active Ceased
- 2019-03-06 US US17/436,244 patent/US20220127317A1/en not_active Abandoned
-
2020
- 2020-03-06 WO PCT/GB2020/050537 patent/WO2020178598A1/en not_active Ceased
- 2020-03-06 CN CN202080034502.XA patent/CN113891719A/zh active Pending
- 2020-03-06 AU AU2020231078A patent/AU2020231078A1/en not_active Abandoned
- 2020-03-06 KR KR1020217031982A patent/KR20210135567A/ko not_active Ceased
- 2020-03-06 JP JP2021552690A patent/JP2022524753A/ja active Pending
- 2020-03-06 EP EP20711271.5A patent/EP3934667A1/en not_active Withdrawn
- 2020-03-06 CA CA3131161A patent/CA3131161A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11466085B2 (en) | Anti-PD-L1 nanobody, coding sequence and use thereof | |
| CN103180339B (zh) | 具有改善的稳定性的基于纤连蛋白的支架蛋白质 | |
| KR101617790B1 (ko) | 치료, 진단과 실험적 혼합물들의 운반을 위한 공학적으로 가변된 나노입자 및 치료용 관련 조성물 | |
| JP2020198875A5 (enExample) | ||
| JP2020182458A5 (enExample) | ||
| JP2020191862A5 (enExample) | ||
| CA3104024A1 (en) | High-affinity t cell receptor against prame | |
| JP6574175B2 (ja) | 細胞透過性ペプチド、及びそれを含むコンジュゲート | |
| WO2021083363A1 (zh) | 一种识别Kras G12V的高亲和力TCR | |
| CN101497666B (zh) | 一种双特异性寡肽-力达霉素强化融合蛋白Ec-LDP-Hr-AE | |
| CN110938136B (zh) | 一种识别afp抗原的高亲和力t细胞受体 | |
| TW202144402A (zh) | 辨識ａｆｐ抗原的高親和力ｔｃｒ | |
| CN111187345B (zh) | 一种识别afp的高亲和力tcr | |
| CN101475643B (zh) | 一种双单链抗体强化融合蛋白dFv-LDP-AE及其制备方法和应用 | |
| WO2021032020A1 (zh) | 一种识别afp的高亲和力t细胞受体 | |
| CN113512124A (zh) | 一种识别hpv16的高亲和力tcr | |
| CN114057864B (zh) | 一种识别afp的高亲和力tcr | |
| WO2023179768A1 (zh) | 一种识别mage-a4抗原的高亲和力tcr及其序列和应用 | |
| TW202144404A (zh) | 一種辨識ａｆｐ抗原的高親和力ｔ細胞受體 | |
| CN109045290B (zh) | 基于内皮细胞特异分子-1的双靶标肿瘤疫苗及其制备方法 | |
| CN115181177A (zh) | 针对afp的t细胞受体 | |
| WO2025051209A1 (zh) | 针对magea4的高亲和力tcr | |
| WO2022166905A1 (zh) | 一种针对hpv的高亲和力tcr | |
| TW202212353A (zh) | 一種辨識ｓｓｘ２抗原的高親和力ｔｃｒ | |
| CN118930660A (zh) | 含有膜型rgd的融合蛋白和表达该融合蛋白的免疫细胞及其应用 |